Monday, Dec 18, 2017
engineered enzymes for better healthcare

Enzolve Technologies 高度创新诊断产品 NeoScreenPak 是一套测试方法,可用于筛检出11 种新生儿最常见遗传性疾病中的 7 种。这些测试将在简单的单一平台上完成,可以替代当前世界上广泛应用的,筛检此类疾病的各种繁复技术。

更多信息

Language Selection

Search

Latest News

Newborn Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…

Read more...

Screen your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…

Read more...

UCD campus company to begin production of newborn screening kits for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…

Read more...